Clinical trials data
Trail Making Test in obesity and diabetes trials: 102 registered studies
Every registered obesity and diabetes study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered obesity and diabetes studies name it in an outcome measure
- 102
- Name it in a primary outcome, 34%
- 35 of 102
Tests named in the same studies
- 1
Stroop Color-Word Test42 studies, 13 as a primary outcome
- 2
Verbal Learning40 studies, 16 as a primary outcome
- 3
Verbal Fluency34 studies, 17 as a primary outcome
- 4
Symbol Coding26 studies, 14 as a primary outcome
- 5
Digit Span Test25 studies, 11 as a primary outcome
- 6
Category Fluency18 studies, 11 as a primary outcome
- 7
Complex Figure Copy and Recall10 studies, 5 as a primary outcome
- 8
Short Story Recall9 studies, 6 as a primary outcome
- 9
Picture Naming Test9 studies, 5 as a primary outcome
- 10
Card Sorting Test (Berg)6 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 2 | 0 |
| 2013 | 4 | 3 |
| 2014 | 1 | 0 |
| 2015 | 5 | 1 |
| 2016 | 7 | 2 |
| 2017 | 3 | 2 |
| 2018 | 6 | 2 |
| 2019 | 7 | 1 |
| 2020 | 2 | 0 |
| 2021 | 8 | 3 |
| 2022 | 12 | 5 |
| 2023 | 6 | 1 |
| 2024 | 8 | 2 |
| 2025 | 12 | 4 |
| 2026 | 11 | 6 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 13 studies, 2 as a primary outcome
- Phase 25 studies, 3 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 2 as a primary outcome
- Phase 44 studies, 2 as a primary outcome
- Not applicable69 studies, 21 as a primary outcome
- Observational17 studies, 5 as a primary outcome
Participants per study
- Not applicable74 median, 33 to 105
- Observational101 median, 60 to 138
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 68 | 74 | 33 to 105 |
| Observational | 17 | 101 | 60 to 138 |
When obesity and diabetes trials measure it
Latest time point of each outcome
- Within a day13 outcomes, 2 as a primary outcome
- Up to 4 weeks7 outcomes, 1 as a primary outcome
- 1 to 3 months27 outcomes, 13 as a primary outcome
- 3 to 6 months25 outcomes, 7 as a primary outcome
- 6 to 12 months14 outcomes, 7 as a primary outcome
- 1 to 2 years4 outcomes, 1 as a primary outcome
- Over 2 years10 outcomes, 2 as a primary outcome
- No duration given2 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
100 of the 102 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting20 studies, 8 as a primary outcome
- Not yet recruiting5 studies, 1 as a primary outcome
- Active, not recruiting8 studies, 3 as a primary outcome
- Completed52 studies, 18 as a primary outcome
- Stopped early8 studies, 3 as a primary outcome
- Status unknown9 studies, 2 as a primary outcome
What they test
- Behavioral34 studies, 12 as a primary outcome
- Drug17 studies, 12 as a primary outcome
- Device5 studies, 1 as a primary outcome
- Dietary supplement13 studies, 3 as a primary outcome
- Procedure8 studies, 1 as a primary outcome
- Diagnostic test1 studies, 0 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Other33 studies, 11 as a primary outcome
- None given7 studies, 3 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States36 studies, 11 as a primary outcome
- Canada9 studies, 3 as a primary outcome
- Denmark7 studies, 2 as a primary outcome
- Spain7 studies, 3 as a primary outcome
- China6 studies, 4 as a primary outcome
- Australia4 studies, 1 as a primary outcome
- Germany4 studies, 1 as a primary outcome
- Brazil3 studies, 1 as a primary outcome
- Thailand3 studies, 3 as a primary outcome
- Belgium2 studies, 1 as a primary outcome
- Egypt2 studies, 1 as a primary outcome
- France2 studies, 0 as a primary outcome
25 countries in all. A study with sites in several counts in each; 5 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed obesity and diabetes studies that name the Trail Making Test: 22 of 52, 42%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed obesity and diabetes studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 4, 8% | 776, 10% |
| Results on ClinicalTrials.gov only | 7, 13% | 1,139, 14% |
| A results paper only | 11, 21% | 1,711, 22% |
| Neither | 30, 58% | 4,327, 54% |
The 102 studies
102 studies match. 35 name the Trail Making Test in a primary outcome. Median size 80 participants. Median time to the primary outcome: 4 months.
Loading 102 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 2 | 0 |
| 2013 | 4 | 3 |
| 2014 | 1 | 0 |
| 2015 | 5 | 1 |
| 2016 | 7 | 2 |
| 2017 | 3 | 2 |
| 2018 | 6 | 2 |
| 2019 | 7 | 1 |
| 2020 | 2 | 0 |
| 2021 | 8 | 3 |
| 2022 | 12 | 5 |
| 2023 | 6 | 1 |
| 2024 | 8 | 2 |
| 2025 | 12 | 4 |
| 2026 | 11 | 6 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 3, other 99. Interventional 85, observational 17.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07870291 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants105 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07820774 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants54 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07750223 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants105 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07704229 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07694596 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants200 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07642518 | Start2026 | PhaseNot applicable | ConditionsMild cognitive impairment, Obesity and diabetes | Participants38 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07501377 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07485062 | Start2026 | PhasePhase 4 | ConditionsAging, frailty and exercise, Obesity and diabetes | Participants164 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07402031 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07374705 | Start2026 | PhaseObservational | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07361874 | Start2026 | PhaseNot applicable | ConditionsObesity and diabetes | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07330700 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants60 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07262788 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants24 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07203196 | Start2025 | PhaseNot applicable | ConditionsAging, frailty and exercise, Obesity and diabetes, Sleep and sleep disorders | Participants16 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07040748 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants84 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06969235 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants10 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06960941 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants24 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06936657 | Start2025 | PhaseNot applicable | ConditionsObesity and diabetes | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06912321 | Start2024 | PhaseObservational | ConditionsObesity and diabetes | Participants400 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06869941 | Start2025 | PhaseObservational | ConditionsObesity and diabetes | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06857994 | Start2025 | PhaseObservational | ConditionsObesity and diabetes, Cardiovascular disease | Participants101 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06781762 | Start2025 | PhaseObservational | ConditionsCancer, Obesity and diabetes | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06781541 | Start2022 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise, Obesity and diabetes, Cardiovascular disease | Participants72 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06734546 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Obesity and diabetes | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06649981 | Start2025 | PhasePhase 1 | ConditionsObesity and diabetes | Participants80 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
Questions, answered from the data
How many obesity and diabetes trials use the Trail Making Test?
102 registered obesity and diabetes studies on ClinicalTrials.gov name it in an outcome measure, 35 of them in a primary outcome: 16% of the condition's 627 studies with a cognitive outcome, against 14% of all of them. It is the 2nd most named test in obesity and diabetes trials.
Which tests do obesity and diabetes trials use with the Trail Making Test?
The Stroop Color-Word Test (42 studies), Verbal Learning (40 studies) and Verbal Fluency (34 studies).
When do obesity and diabetes trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 4 months of the start, and the middle half from 12 weeks to 11 months. 33 primary outcomes give a duration.
How many completed obesity and diabetes trials that use the Trail Making Test have reported results?
22 of the 52 completed studies that name it, 42%, have reported results: 11 posted them on ClinicalTrials.gov, 15 have a results paper linked to the registry record, and 4 did both. The other 30 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.